We are live on
!
Find out more
BIM
Bogle Investment Management Portfolio holdings
AUM
$63M
1-Year Est. Return
51.97%
This Fund
S&P 500
This Quarter
Est. Return
+6.85%
1 Year Est. Return
+51.97%
3 Year Est. Return
+181.13%
5 Year Est. Return
+959%
10 Year Est. Return
–
AUM
$1.5B
AUM Growth
+$109M
(+7.9%)
Cap. Flow
+$60.5M
Cap. Flow
% of AUM
4.04%
Top 10 Holdings %
Top 10 Hldgs %
11.4%
Holding
548
New
180
Increased
104
Reduced
85
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bausch Health
BHC
|
+$31M |
| 2 |
Alkermes
ALKS
|
+$17M |
| 3 |
Herc Holdings
HRI
|
+$16M |
| 4 |
DCH
Dauch Corp
DCH
|
+$15.4M |
| 5 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$14.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Manhattan Associates
MANH
|
+$15M |
| 2 |
Take-Two Interactive
TTWO
|
+$14.4M |
| 3 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$13.6M |
| 4 |
NetEase
NTES
|
+$13.1M |
| 5 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$12.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 17.13% |
| 2 | Industrials | 16.2% |
| 3 | Healthcare | 15.95% |
| 4 | Technology | 13.15% |
| 5 | Materials | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Enova International
ENVA
$6.44B
| $878K | 0.06% |
139,180
-100,514
| -42% | -$600K |
|
277
Stoneridge
SRI
$210M
| $878K | 0.06% |
+60,327
| New | +$759K |
|
|
FNSR
278
DELISTED
Finisar Corp
FNSR
| $873K | 0.06% |
+47,900
| New | +$689K |
|
279
Inogen
INGN
$182M
| $861K | 0.06% |
+19,150
| New | +$682K |
|
280
First Bancorp
FBP
$4.43B
| $853K | 0.06% |
292,416
| – | – |
|
|
MGI
281
DELISTED
MoneyGram International, Inc. New
MGI
| $844K | 0.06% |
138,055
+50,097
| +57% | +$283K |
|
282
NACCO Industries
NC
$363M
| $841K | 0.06% |
+64,167
| New | +$711K |
|
|
GBL
283
DELISTED
GAMCO Investors, Inc.
GBL
| $840K | 0.06% |
+22,681
| New | +$739K |
|
|
COHR
284
DELISTED
Coherent Inc
COHR
| $836K | 0.06% |
+9,100
| New | +$701K |
|
285
Great Southern Bancorp
GSBC
$886M
| $831K | 0.06% |
+22,406
| New | +$869K |
|
|
TVTY
286
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $831K | 0.06% |
+82,367
| New | +$925K |
|
287
AngioDynamics
ANGO
$627M
| $827K | 0.06% |
67,327
-45,788
| -40% | -$506K |
|
|
BRCD
288
DELISTED
Brocade Communications Systems, Inc. NEW
BRCD
| $806K | 0.05% |
76,211
-23,834
| -24% | -$217K |
|
|
VIA
289
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $801K | 0.05% |
+17,803
| New | +$1.04M |
|
290
Build-A-Bear
BBW
$424M
| $786K | 0.05% |
+60,524
| New | +$777K |
|
|
AFSI
291
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $755K | 0.05% |
+29,200
| New | +$776K |
|
292
UNIFI
UFI
$119M
| $751K | 0.05% |
+32,809
| New | +$779K |
|
293
Civeo
CVEO
$339M
| $750K | 0.05% |
50,874
-15,299
| -23% | -$203K |
|
294
La-Z-Boy
LZB
$1.64B
| $740K | 0.05% |
+27,696
| New | +$648K |
|
|
LDRH
295
DELISTED
LDR HOLDINGS CORP COM STK
LDRH
| $739K | 0.05% |
28,996
+8,648
| +43% | +$181K |
|
296
iRadimed
IRMD
$1.17B
| $731K | 0.05% |
38,171
-3,494
| -8% | -$66.9K |
|
297
StoneX
SNEX
$9.22B
| $730K | 0.05% |
138,348
-268,824
| -66% | -$1.45M |
|
|
BBG
298
DELISTED
Bill Barrett Corp
BBG
| $728K | 0.05% |
+117,055
| New | +$469K |
|
|
GNMK
299
DELISTED
GenMark Diagnostics, Inc
GNMK
| $721K | 0.05% |
136,821
+122,213
| +837% | +$680K |
|
|
BSTC
300
DELISTED
BioSpecifics Technologies Corp.
BSTC
| $714K | 0.05% |
+20,530
| New | +$753K |
|
Similar funds
FC
NISOA
UMA
HS
DFG
SRCM
OFM
SAM
Bogle Investment Management's Q1 2016 Portfolio in Review
As of Q1 2016, Bogle Investment Management held 548 positions worth $1.5B, up 7.9% from $1.39B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Bogle Investment Management deployed $60.5M of net new capital in Q1 2016, opening 180 new positions and adding to 104 existing holdings. Its largest new stake was Bausch Health: 419,115 shares worth $11M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 17% of assets, up from 15% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was New Oriental, an estimated $11M trimmed.
- Bogle Investment Management's largest Q1 2016 buy was Bausch Health: 419,115 shares worth $11M.
- Bogle Investment Management added most to Herc Holdings in Q1 2016, an estimated $16M increase.
- Bogle Investment Management's biggest Q1 2016 reduction was New Oriental, cutting an estimated $11M.
- Bogle Investment Management fully exited Manhattan Associates in Q1 2016, selling an estimated $15M.
- Bogle Investment Management's ten largest holdings make up 11% of its $1.5B portfolio in Q1 2016.
- Bogle Investment Management opened 180 new positions and closed 172 in Q1 2016.
- Bogle Investment Management's portfolio value rose 7.9% quarter-over-quarter to $1.5B.
Based on Bogle Investment Management's 13F filing for Q1 2016, filed 13 May 2016.